Bluephage’s Rapid Kit means a true Revolution in the water industry. Our patented technology allows the detection and enumeration of coliphages in less than 6.5h.
Bluephage’s Rapid Kit means a true Revolution in the water industry. Our patented technology allows the detection and enumeration of coliphages in less than 6.5h.
Water without these coliphages is considered pathogen-free, and more importantly, safe drinking water.
Water without these coliphages is considered pathogen-free, and more importantly, safe drinking water.
“We aim to positively contribute to the global water crisis, and now, in 2021, we are proud to have achieved B-Corporation status, recognizing and reinforcing our mission to provide Safe Water for a Better World”
Enric Queralt
Bluephage CEO
Discover Bluephage Rapid Kit
The Bluephage Rapid Kit is the innovative and disruptive technology for coliphage detection that supports water industry professionals all the way to a revolution in transforming and upgrading their laboratories.
The Bluephage Rapid Kit is the innovative and disruptive technology for coliphage detection that supports water industry professionals all the way to a revolution in transforming and upgrading their laboratories.
Bluephage provides its customers with the necessary and disruptive elements for a new approach to water analysis that will revolutionise the way the world monitors water quality, making it the closest technique to real-time monitoring.
be part of our vision
Safe water for a better world
be part of our vision
Safe water for a better world
The quickest, most accurate and easy-to-use viral indicator tests available for microbial water quality assessment
MAIN CHARACTERISTICS
quick results
< 6’5 hours
equivalence
To ISO and US-EPA standard methods
easy-to-use
Basic laboratory equipment
high sensitivity
Low limit of 1pfu/100 mL
easy storage
Biological material at -20ºC
Rest of components at Room Temperature
effective test results
Presence/Absence
Quantitative
Bluephage solution
Bluephage now offers an innovative and patented technology that allows rapid, easy, and cost-effective detection and enumeration of coliphages in one working day versus the time required by standardized methods.
Discover Bluephage’s portfolio of products and simplify and accelerate the coliphage enumeration process in water analysis.
The quickest, most accurate and easy-to-use viral indicator tests available for microbial water quality assessment
MAIN CHARACTERISTICS
Bluephage solution
Bluephage now offers an innovative and patented technology that allows rapid, easy, and cost-effective detection and enumeration of coliphages in one working day versus the time required by standardized methods.
Discover Bluephage’s portfolio of products and simplify and accelerate the coliphage enumeration process in water analysis.
quick results
< 6’5 hours
easy-to-use
Basic laboratory equipment
easy storage
Biological material at -20ºC
Rest of components at Room Temperature
equivalence
To ISO and US-EPA standard methods
high sensitivity
Low limit of 1pfu/100 mL
effective test results
Presence/Absence
Quantitative
a new approach for water testing
Why Coliphages
billion people
without access to
safe drinking water
disease
associated with
contaminated water worldwide
million hospitalizations
a year in developed countries
due to waterborne pathogens
“The World Health Organization, the US-EPA, and the European Commission have recently recognized the coliphage test as a new viral indicator. The presence of coliphages equals tainted water; the absence of coliphages means safe water. This is because bacterial indicators, still widely used, have significant limitations and inefficiencies, especially when looking at viral pathogens in water.”
Anicet R. Blanch
Bluephage CTO and Co-Founder
blog and news
Bluephage will be exhibiting at IFAT in Munich, the leading trade fair for environmental technologies, from 30 May to 3 June
BLOG | Bluephage Bluephage will present the Qualitative Rapid Kit for coliphage detection at the...
Conclusions and recording of the webinar: Past, present, and future of coliphages
BLOG | BluephageOn 21 April 2022, Bluephage hosted the webinar "Past, Present and Future of...
The pandemic has shown that we need more viral indicators
BLOG | BluephageBluehage interviews Mariana Fittipaldi of IELAB to discuss best practices in...
member of
incubated by
Sponsored by CDTI
Part of this project has been financed by the general budgets of the spanish state in charge of the application 27.12.467C.74908
